US to speed up payments for new medical devices
Regulators hand industry a lobbying victory after fierce effort to get faster coverage for their products
Regulators hand industry a lobbying victory after fierce effort to get faster coverage for their products

Cheaper generics will be allowed on to market a year earlier to curb costs

Move is latest broadside by Trump administration against pharmaceuticals industry that fought to derail changes

UK government will make it easier for drugs to be approved for use in order to secure carve-out from import levies

Corporates try to take advantage of market rebounds rather than risk further turbulence or US midterm elections

Plus the social media lawsuits

Fast-growing market comes under greater scrutiny for potential risks after series of setbacks